4Israili ZH, HallWD. Cough and angioneurotic edema associated with angiotensin converting enzyme inhibitor therapy. A review of the literature and pathophysiology. Ann Intern Med, 1992, 117:234-342.
5Tan SA, Tan LC. Increased tachykinin A not bradykinin causes the ACE inhibitor induced cough. J Heart Failure, 1998, 5: 120-127.
6ZWEIKER R, STOSCHITZKY K, MAIER R, et al. Efficacy and safety of the ACEI hibitor Imidapril in patients with essential hypertension [J]. Acta MedAustriaca ,2002 ,29 : 72 - 76.
7MurataT, MarsumotoY, KashidaT, et al. Difference among angiotensin coverting enzyme inhibitors in potentiating effects on bradykinin induced microvaseular leakage in guinea pig airways.Jpn J Phamacol, 1995,69:111-118.
8Kearney PM,Whelton M, Reynolds K, et al. Global burden of hy- pertension: analysis of worldwide data [ J ]. Lancet, 2005, 365 (9455) :217 - 223.
9Campbell DB,Phllips EM. Short Term effects and urinary excretion of the new diuretic, indapamie, in normal subjects [ J ]. Eur J Clin Pharmacol, 1974,7 ( 6 ) :407 - 414.
10Franz IW, Lohmann FW. The influence of a combined diurectic-be- ta-rcceptorblocker therapy on elevated exercise blood pressure,erqo- metric investigations in hypertensive patients (author transl) [ J]. Med kin,1979,74(ll) :396 -400.
